Financials

Estimates*

Edit
Revenues, earnings & profits over time
EUR201820192020202120222023
Revenues81.8m95.3m145m154m163m173m
% growth-17 %52 %6 %6 %6 %
EBITDA1.3m<1m(<1m)<1m(1.4m)-
% EBITDA margin2 %---(1 %)-
Profit<1m(<1m)(1.8m)(<1m)(1.4m)-
% profit margin-(1 %)(1 %)-(1 %)-
  • Edit
DateInvestorsAmountRound
-

N/A

-

N/A

Growth Equity VC
Total Funding-

Recent News about Newpharma

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.